5-Fluoro-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole

Catalog No. :
ACPUJX075
CAS No. :
1628703-47-8
Molecular Formula :
C14H17BFNO2
Molecular Weight :
261.11

IUPAC Name:5-fluoro-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole

5-Fluoro-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$104.00Login to see priceIn stockInquiry
250mg95%$164.00Login to see priceIn stockInquiry
1g95%$392.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-Fluoro-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole
IUPAC Name5-fluoro-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole
MDL No.MFCD31390771
Molecular FormulaC14H17BFNO2
Molecular Weight261.11
SMILESCC1(C)C(C)(C)OB(C2=CC3=C(C=C2F)C=CN3)O1
InChI KeyQKBKZPQPGKUTFZ-UHFFFAOYSA-N
Synonym1H-Indole, 5-fluoro-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-
CAS No.1628703-47-8

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H315-H319
Precautionary Statement(s)
P264-P280-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362

Synthetic Route by SureRoute

1. ACPUJX075 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTOBU801 route compound structure diagram
    ACTOBU80173183-34-3 In Stock
  2. Plus
  3. ACPHCB710 route compound structure diagram
    ACPHCB710259860-08-7 In Stock
  4. Then
  5. ACPUJX075 route product structure diagram
    ACPUJX0751628703-47-8 In Stock
Inquiry

2. ACPUJX075 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTOBU801 route compound structure diagram
    ACTOBU80173183-34-3 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACPUJX075 route product structure diagram
    ACPUJX0751628703-47-8 In Stock
Inquiry

Comments (0)